medigraphic.com
Instituto Nacional de Salud Pública

2014, Number 4

Next >>

salud publica mex 2014; 56 (4)

Cartas al editor

Language: Spanish
References: 19
Page: 311-316
PDF size: 223.46 Kb.


Text Extraction

No abstract


REFERENCES

  1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34(28):2159-2219.

  2. Segura L, Agusti R, Parodi J. Factores de riesgo de las enfermedades cardiovasculares en el Perú. Estudio Tornasol. Rev Per Cardiol 2006;32(2):82-128.

  3. Segura-Vega L, Agustí CR, Ruiz-Mori E. La hipertensión arterial en el Perú según el estudio Tornasol II. Rev Peru Cardiol Lima 2011;37(1):19-27.

  4. Ruiz-Mori E, Segura-Vega L, Rodríguez-Montes de Oca J. Guía de diagnóstico y tratamiento de la hipertensión arterial. “De la teoría a la práctica” [monografía en internet]. Perú: Sociedad Peruana de Cardiología, 2011. Disponible en: http://www. cmp.org.pe/documentos/librosLibres/guia_hipertension/ guia_hipertension.pdf

  5. World Health Organization. A primary health care strategy for the integrated management of respiratory conditions in people of five years of age and over. Geneva: WHO, 2005.

  6. World Health Organization. Practical approach to lung health: “manual on initiating PAL implementation” [monografía en internet]. Geneva: WHO, 2008 [consultado el 20 de febrero de 2014]. Disponible en: http://whqlibdoc.who.int/ hq/2008/WHO_HTM_TB_2008.410_eng.pdf.

  7. Instituto Nacional de Enfermedades Respiratorias “Dr. Emilio Coni”. Abordaje práctico de la salud pulmonar del adulto: guía para el primer nivel de atención. Santa Fe, Argentina: INER, 2012.

  8. Me’emary F, Ottmani S, Pio A, Baghdadi S, Assafin G, Koraym M, et al. Results of the feasibility test of the practical approach to lung health in the Syrian Arab Republic. East Mediterr Health J 2009;15: 504-515.

  9. Zidouni N, Baough L, Laid Y, Chaulet P. Practical approach to lung health strategy in Algeria. Int J Tuberc Lung Dis 2009;13:1029-1037.

  10. Gómez-Dantés O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J. The health system of Mexico. Salud Publica Mex 2011;53 suppl2:S220-S232.

  11. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes 2009;33:289-295.

  12. Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab 2011;36:570-576.

  13. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 2011;183(14):E1059-E1066.

  14. Buchwald H, Avidor Y, Braunwald E, Jansen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1737.

  15. Samet JM, Alberg AJ, Ford JG. Epidemiology of lung cancer and mesothelioma. Eur Respir Mon 2009;44:349-391.

  16. Aguilar-Madrid G, Juárez-Pérez CA, Markowitz S, Hernández-Ávila M, Sánchez-Román FR, Vázquez-Grameix JH. Globalization and the transfer of hazardous industry: asbestos in Mexico, 1979-2000. Int J Occup Environ Health 2003;9(3):272-279.

  17. Weil H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med 2004;61:438-441.

  18. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Industrial Health 2007;45:379-387.

  19. Scagliotti GV. Symptoms, signs and staging of lung cancer. In: Spiro SG. Lung cancer. Eur Respir Mon 2001;17:86-119.




2020     |     www.medigraphic.com